A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
Status:
Completed
Trial end date:
2012-12-04
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the safety of MK-0954A (L100/H12.5 mg) in essential
hypertension participants who are uncontrolled with MK-954H (L50/H12.5 mg).